Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma

Yonsei Medical Journal

Volumn 43, Issue 3, 2002, Pages 304-308

  Jang, Tae Jung ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Basal cell carcinoma; Bowen's disease; CD40; FasL; Squamous cell carcinoma

Indexed keywords

CD40 ANTIGEN; CELL SURFACE RECEPTOR; FAS ANTIGEN; FAS LIGAND;

APOPTOSIS; ARTICLE; BASAL CELL; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER GROWTH; CARCINOGENESIS; CELL MEMBRANE; CELL TYPE; CONTROLLED STUDY; EPIDERMIS; GRANULAR CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PROTEIN EXPRESSION; SKIN CARCINOMA; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA;

EID: 0036309434     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2002.43.3.304     Document Type: Article

References (22)

1. CD40-CD40 ligand: A multifunctional receptor-ligand pair
2. Concurrent engagement of CD40 and the antigen receptor proteins naive and memory human B cells from Apo-1/Fas-mediated apoptosis
3. The CD40 antigen and its ligand
4. Role for CD40-CD40 ligand interactions in the immune response to solid tumors
5. CD40 expression in epidermoid tumors
6. Expression of and CD40 and CD40 ligand in Bowen's disease and squamous cell carcinoma
7. Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: Opposite effects of CD95 and CD40 stimulation
8. Fas mediated apoptosis in human prostatic carcinoma cell lines
9. CD40 is a prognostic marker in primary cutaneous malignant melanoma
10. CD40 expression on human lung cancer correlates with metastatic spread
11. Apoptosis by death factor
12. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
13. Fas ligand and immune evasion
14. Fas ligand-induced apoptosis as a mechanism of immune privilege
15. A role for CD95 ligand in preventing graft rejection
16. Melanoma cell expression of Fas (Apo-1/CD95) ligand implications for tumor immune escape
17. Human lung carcinomas express Fas ligand
18. Up-regulation of Fas (Apo-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer
19. The role of CD40/CD154 interactions in the priming, differentiation and effector function of helper and cytotoxic T cells
20. Fas ligand is expressed in normal skin and in some cutaneous malignancies
21. The Fas counterattack in vivo: Apoptotic depletion of tumor-infiltrating lymphocytes associated with FasL expression by human esophageal carcinoma
22. The incidence of basal cell carcinoma and their metastasis in Australia and New Zealand